P I Borgen

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Patient regrets after bilateral prophylactic mastectomy
    P I Borgen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 5:603-6. 1998
  2. ncbi request reprint Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma
    S K Boolbol
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:20-4. 2001
  3. ncbi request reprint Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures
    H S Cody
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:13-9. 2001
  4. ncbi request reprint The breast cancer patient with multiple sentinel nodes: when to stop?
    M D McCarter
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 192:692-7. 2001
  5. ncbi request reprint Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma
    G H Ho
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Breast Cancer Res Treat 65:225-32. 2001
  6. ncbi request reprint Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes
    M R Weiser
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:145-9. 2001
  7. ncbi request reprint Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection
    M D McCarter
    The Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:682-6. 2001
  8. ncbi request reprint Issues of regret in women with contralateral prophylactic mastectomies
    L L Montgomery
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 6:546-52. 1999
  9. ncbi request reprint Is there a role for selective axillary dissection in breast cancer?
    M L Gemignani
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    World J Surg 25:809-18. 2001
  10. ncbi request reprint State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center
    H S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    Surg Oncol 8:85-91. 1999

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Patient regrets after bilateral prophylactic mastectomy
    P I Borgen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 5:603-6. 1998
    ....
  2. ncbi request reprint Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma
    S K Boolbol
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:20-4. 2001
    ..Further investigation is warranted before this technique is adopted for use in larger breast cancers. Intraoperative examination and biopsy of any suspicious nonsentinel nodes are critical...
  3. ncbi request reprint Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures
    H S Cody
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:13-9. 2001
    ..Despite this, few studies examine in detail the factors contributing to the success of these techniques, either individually or in combination...
  4. ncbi request reprint The breast cancer patient with multiple sentinel nodes: when to stop?
    M D McCarter
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 192:692-7. 2001
    ..A significant minority of patients have 4 or more SLNs. Here we seek to determine the significance for the breast cancer patient of finding multiple SLNs, and whether there is an optimal threshold number of SLNs that should be removed...
  5. ncbi request reprint Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma
    G H Ho
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Breast Cancer Res Treat 65:225-32. 2001
    ..Although p14ARF mutations and HDM2 gene amplification appear to be uncommon events in breast carcinoma, deregulation of this pathway may occur via alternative mechanisms in breast carcinogenesis...
  6. ncbi request reprint Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes
    M R Weiser
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:145-9. 2001
    ..CONCLUSION: Patients with small breast cancers, no LVI, and SLN micrometastases have a low risk of non-SLN metastases, and may not require completion ALND...
  7. ncbi request reprint Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection
    M D McCarter
    The Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:682-6. 2001
    ..CONCLUSIONS: The results of SLN mapping with same-day and day-before injection of radioisotope are virtually identical. The logistical advantages of day-before injection do not compromise the success of the procedure...
  8. ncbi request reprint Issues of regret in women with contralateral prophylactic mastectomies
    L L Montgomery
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 6:546-52. 1999
    ..We have developed a National Prophylactic Mastectomy Registry comprised of a volunteer population of 817 women from 43 states who have undergone prophylactic (unilateral or bilateral) mastectomy...
  9. ncbi request reprint Is there a role for selective axillary dissection in breast cancer?
    M L Gemignani
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    World J Surg 25:809-18. 2001
    ....
  10. ncbi request reprint State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center
    H S Cody
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    Surg Oncol 8:85-91. 1999
    ..10% of positive SLN were found by isotope alone, and 11% by dye alone. Failed and false-negative SLN procedures were less frequent as experience increased...
  11. ncbi request reprint Highest isotope count does not predict sentinel node positivity in all breast cancer patients
    R C Martin
    The Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:592-7. 2001
    ..Having removed the SLN with the highest counts, how far should the surgeon persist in removing additional SLN which contain much lower levels of isotope?..
  12. ncbi request reprint A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer
    J L B Bevilacqua
    Department of Surgery and Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur J Surg Oncol 28:603-14. 2002
    ..Based on our review, we propose an algorithm for a selective approach to IM-SLN in breast cancer...
  13. ncbi request reprint Women's regrets after bilateral prophylactic mastectomy
    D K Payne
    Barbara White Fishman Center for Psychological Counseling of the Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 7:150-4. 2000
    ..Primary prevention strategies such as chemopreventive agents (e.g., tamoxifen) and bilateral prophylactic mastectomy (PM) have received increasingly more attention as management options for women at high risk of developing breast cancer...
  14. ncbi request reprint Sentinel lymph node biopsy in patients with male breast carcinoma
    E R Port
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 91:319-23. 2001
    ..SLNB is aimed at preventing these morbidities. In this study, the authors evaluated the role of SLNB in the treatment of men with early stage breast carcinoma...
  15. ncbi request reprint Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas
    M Bisogna
    Department of Surgery, The Breast Cancer Research Laboratory, Memorial Sloan-Kettering Cancer Center, 10021, New York, NY, USA
    Cancer Genet Cytogenet 125:131-8. 2001
    ....
  16. ncbi request reprint Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations
    N D Kauff
    Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Genet Med 3:422-5. 2001
    ..CONCLUSION: Insurance carriers reimbursed the vast majority of BRCA mutation carriers undergoing risk-reducing surgery...
  17. ncbi request reprint Patient reluctance toward tamoxifen use for breast cancer primary prevention
    E R Port
    Breast Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:580-5. 2001
    ..CONCLUSIONS: In this study, the vast majority of patients at increased risk for breast cancer perceived that the risks of taking tamoxifen outweighed the benefits and declined to take it...
  18. ncbi request reprint Current status of tamoxifen use: An update for the surgical oncologist
    A S Heerdt
    Breast Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Surg Oncol 72:42-9. 1999
    ..It is important for the surgical oncologist to understand the current indications and evidence regarding the use of tamoxifen for breast cancer prevention and treatment as they counsel their patients on available options...
  19. ncbi request reprint Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer
    R C Martin
    Breast Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Surgery 130:432-8. 2001
    ..The dermal and parenchymal lymphatics of the breast drain to the same axillary SLN in most breast cancer patients, and ID isotope injection is the procedure of choice in this setting...
  20. ncbi request reprint Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer
    M L Quan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 10:1048-53. 2003
    ..We determined the utility of magnetic resonance imaging (MRI) in finding otherwise unsuspected cancer in the ipsilateral or contralateral breast of patients with ILC...
  21. ncbi request reprint Biological behavior of human breast cancer micrometastases
    N Klauber-DeMore
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Clin Cancer Res 7:2434-9. 2001
    ..7%; P = not significant). CONCLUSIONS: Human breast cancer micrometastases have lower tumor proliferation rates and angiogenesis than breast cancer macrometastases. These characteristics may explain their differential growth patterns...
  22. pmc Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases
    S W Kim
    Gynecology and Breast Research Laboratory and Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    J Med Genet 42:e5. 2005
  23. ncbi request reprint Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome
    J Boyd
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Breast Cancer Res Treat 53:87-91. 1999
    ..We conclude that hereditary male breast cancer can occur as an integral tumor in the HNPCC syndrome...
  24. ncbi request reprint N-cadherin promotes adhesion between invasive breast cancer cells and the stroma
    R B Hazan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cell Adhes Commun 4:399-411. 1997
    ..The combined results suggest a functional role for N-cadherin in cohesion of breast tumor cells which, in addition promotes their interaction with the surrounding stromal cells, thereby facilitating invasion and metastasis...
  25. ncbi request reprint A prospective validated model for predicting axillary node metastases based on 2,000 sentinel node procedures: the role of tumour location [corrected]
    J Bevilacqua
    Department of Surgery and Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur J Surg Oncol 28:490-500. 2002
    ....